economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

Galderma

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss OG_NewsReleaseCompanyLogo_93126.jpg

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

creativebharatgroup@gmail.com January 14, 2025
Zug, Switzerland:    Three-month interim data from first-of-its-kind trial demonstrate that the...
Read More Read more about Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis OG_NewsReleaseCompanyLogo_92873.jpg

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

creativebharatgroup@gmail.com December 14, 2024
Zug, Switzerland:   Ad hoc announcement pursuant to Art. 53 LR   ...
Read More Read more about Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis